| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.60B | 28.71B | 25.75B | 22.35B | 19.83B | 18.29B |
| Gross Profit | 24.60B | 24.03B | 21.64B | 18.46B | 16.43B | 13.70B |
| EBITDA | 9.64B | 12.51B | 11.24B | 9.26B | 8.93B | 8.01B |
| Net Income | 5.65B | 5.93B | 5.41B | 4.40B | 4.35B | 2.45B |
Balance Sheet | ||||||
| Total Assets | 72.21B | 69.45B | 66.78B | 63.38B | 59.70B | 57.00B |
| Cash, Cash Equivalents and Short-Term Investments | 12.22B | 14.72B | 12.99B | 11.18B | 9.02B | 5.17B |
| Total Debt | 7.83B | 8.56B | 9.94B | 12.21B | 14.19B | 16.16B |
| Total Liabilities | 27.06B | 27.60B | 27.68B | 28.80B | 29.08B | 31.32B |
| Stockholders Equity | 45.12B | 41.79B | 39.07B | 34.52B | 30.54B | 25.68B |
Cash Flow | ||||||
| Free Cash Flow | 7.14B | 7.81B | 7.35B | 6.78B | 6.34B | 4.46B |
| Operating Cash Flow | 7.31B | 8.20B | 7.84B | 6.87B | 6.44B | 4.95B |
| Investing Cash Flow | -3.22B | -1.60B | -1.60B | -1.00B | -532.55M | -134.88M |
| Financing Cash Flow | -5.79B | -4.86B | -4.46B | -3.75B | -2.08B | -4.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥73.96B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
70 Outperform | ¥91.39B | 18.51 | ― | 1.02% | 26.47% | 142.77% | |
66 Neutral | ¥89.07B | 20.24 | ― | 2.59% | 5.22% | -6.62% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥121.67B | 293.64 | ― | ― | 31.57% | ― | |
45 Neutral | ¥53.47B | 43.64 | ― | ― | 8.98% | -581.59% | |
44 Neutral | ¥38.34B | 16.46 | ― | ― | 27.58% | -1.50% |